Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2005 1
2006 2
2011 1
2012 2
2013 1
2014 1
2016 1
2017 2
2018 2
2019 3
2020 1
2021 4
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
Peterse EFP, Niessen B, Addie RD, de Jong Y, Cleven AHG, Kruisselbrink AB, van den Akker BEWM, Molenaar RJ, Cleton-Jansen AM, Bovée JVMG. Peterse EFP, et al. Among authors: kruisselbrink ab. Br J Cancer. 2018 Apr;118(8):1074-1083. doi: 10.1038/s41416-018-0050-9. Epub 2018 Mar 26. Br J Cancer. 2018. PMID: 29576625 Free PMC article.
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target.
Franceschini N, Gaeta R, Krimpenfort P, Briaire-de Bruijn I, Kruisselbrink AB, Szuhai K, Palubeckaitė I, Cleton-Jansen AM, Bovée JVMG. Franceschini N, et al. Among authors: kruisselbrink ab. Lab Invest. 2022 Apr;102(4):391-400. doi: 10.1038/s41374-021-00709-z. Epub 2021 Dec 17. Lab Invest. 2022. PMID: 34921235 Free PMC article.
Histone Deacetylase Inhibitors as a Therapeutic Strategy to Eliminate Neoplastic "Stromal" Cells from Giant Cell Tumors of Bone.
Venneker S, van Eenige R, Kruisselbrink AB, Palubeckaitė I, Taliento AE, Briaire-de Bruijn IH, Hogendoorn PCW, van de Sande MAJ, Gelderblom H, Mei H, Bovée JVMG, Szuhai K. Venneker S, et al. Among authors: kruisselbrink ab. Cancers (Basel). 2022 Sep 27;14(19):4708. doi: 10.3390/cancers14194708. Cancers (Basel). 2022. PMID: 36230631 Free PMC article.
24 results